Statistics

Total Visits

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants66

Select a period of time:

Number of views in the range

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants32

Views

Views
January 20252
February 20257
March 202514
April 20253
May 20251
June 20254
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Singapore14
Spain1
United Kingdom1
 

Top cities views

Views
Buffalo1
Conyers1
Council Bluffs1
Pasadena1
Scottsdale1